1. 赫捷 中国 中国医学科学院 中国科学院院士 Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for local..
2. 赫捷 中国 中国医学科学院 中国科学院院士 Comparison of neoadjuvant nab-paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for..
3. Karlan, Beth Y. 美国 David Geffen School of Medicine at UCLA 2015美国医学院院士 FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer
4. 樊代明 中国 空军军医大学 中国工程院院士;2013美国医学院院士 The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor..
5. 梁文华 中国 广州医科大学 Upfront surgery for stage IIIA/B non-small cell lung cancer: retrospective cohort study
6. 何建行 中国 广州医科大学 院长 Upfront surgery for stage IIIA/B non-small cell lung cancer: retrospective cohort study
7. 刘芝华 中国 中国医学科学院 Progenitor-like exhausted SPRY1+CD8+T cells potentiate responsiveness to neoadjuvant PD-1 blockade i..
8. 何建行 中国 广州医科大学 院长 Robotic-assisted navigation system for preoperative lung nodule localization: a pilot study
9. 何建行 中国 广州医科大学 院长 A surgical Decision-making scoring model for spontaneous ventilation- and mechanical ventilation-vid..
10. Yuko,Kitagawa 日本 Keio University Updates of perioperative multidisciplinary treatment for surgically resectable esophageal cancer
11. Juan A,Rosado 西班牙 UNIVERSIDAD DE EXTREMADURA Secretion of Interleukin 6 in Human Skeletal Muscle Cultures Depends on Ca2+ Signalling
12. 韩宝惠 中国 上海交通大学医学院 主任医师 Effect and outcomes analysis of anlotinib in non-small cell lung cancer patients with liver metastas..
13. Yuko,Kitagawa 日本 Keio University A nationwide validation of the prognostic impact of pathological response and the distribution of re..
14. Manabu,Muto 日本 Kyoto University A nationwide validation of the prognostic impact of pathological response and the distribution of re..
15. Hiroya,Takeuchi 日本 Hamamatsu University School of Medicine A nationwide validation of the prognostic impact of pathological response and the distribution of re..
16. Yuichiro,Doki 日本 Osaka University A nationwide validation of the prognostic impact of pathological response and the distribution of re..
17. 田捷 中国 北京航空航天大学 PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistanc..
18. 吴一龙 中国 广东省人民医院 PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistanc..
19. 谢东 中国 中国科学院 PES1 reduces CD8+ T cell infiltration and immunotherapy sensitivity via interrupting ILF3..
20. 陈海泉 中国 复旦大学上海医学院 主任医师 Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for local..